Оne-way sensitivity analysis of treatment costs for tyrosine kinase inhibitors in first- and second- lines therapy of patients with CML–CP (Tornado diagram). Variation of the drug costs with ± 25% of the prices. The values are presented in Bulgarian monetary currency /BGN/.

 
 
  Part of: Goranova-Marinova V, Grekova-Kafalova D, Andreevska K, Georgieva V, Gvozdeva Y, Kassarova M, Grudeva-Popova Z, Gavazova E, Petkova V (2024) Analysis of the pharmacoeconomic effectiveness of the tyrosine kinase inhibitors therapy in patients with chronic myeloid leukemia in a Single Hematology Center in Plovdiv, Bulgaria. Pharmacia 71: 1-19. https://doi.org/10.3897/pharmacia.71.e126016